Bibliographic Info
GuidelineGuidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year of Publication2024
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Moderate
Measuring HBV DNA to guide treatment eligibility and monitor the response. Laboratory-based HBV DNA assays: Directly following a positive HBsAg serological test result, the use of HBV DNA nucleic acid testing (NAT) (quantitative or qualitative) is recommended as the preferred strategy to assess viral load level for treatment eligibility and to monitor treatment response
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines on hepatitis B and C testing.
Year2017
InstitutionWHO